PT1761520E - Inibidores de quinase - Google Patents

Inibidores de quinase Download PDF

Info

Publication number
PT1761520E
PT1761520E PT05766569T PT05766569T PT1761520E PT 1761520 E PT1761520 E PT 1761520E PT 05766569 T PT05766569 T PT 05766569T PT 05766569 T PT05766569 T PT 05766569T PT 1761520 E PT1761520 E PT 1761520E
Authority
PT
Portugal
Prior art keywords
kinase inhibitors
formula
present
inhibitors
provides kinase
Prior art date
Application number
PT05766569T
Other languages
English (en)
Inventor
Chuan Shih
Beatriz Lopez De Uralde Garmendia
Alfonso De Dios
Tiechao Li
Luisa Maria Martin Cabrejas
Mark Andrew Pobanz
Yong Wang
Boyu Zhong
Jesus Andres Blas
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04380131A external-priority patent/EP1609789A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT1761520E publication Critical patent/PT1761520E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT05766569T 2004-06-23 2005-06-15 Inibidores de quinase PT1761520E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04380131A EP1609789A1 (en) 2004-06-23 2004-06-23 Ureido-pyrazole derivatives and their use as kinase inhibitors
US59253904P 2004-07-30 2004-07-30
EP04380174 2004-08-23
US62249204P 2004-10-27 2004-10-27

Publications (1)

Publication Number Publication Date
PT1761520E true PT1761520E (pt) 2008-09-15

Family

ID=43875180

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05766569T PT1761520E (pt) 2004-06-23 2005-06-15 Inibidores de quinase

Country Status (9)

Country Link
US (1) US7767674B2 (pt)
EP (1) EP1761520B1 (pt)
AT (1) ATE400567T1 (pt)
DK (1) DK1761520T3 (pt)
ES (1) ES2308523T3 (pt)
PL (1) PL1761520T3 (pt)
PT (1) PT1761520E (pt)
SI (1) SI1761520T1 (pt)
WO (1) WO2006009741A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4943837B2 (ja) 2003-04-03 2012-05-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 可溶性エポキシド加水分解酵素の改良インヒビター
JP2007532484A (ja) 2004-03-16 2007-11-15 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法
WO2006045119A2 (en) 2004-10-20 2006-04-27 The Regents Of The University Of California Improved inhibitors for the soluble epoxide hydrolase
AR056582A1 (es) * 2005-10-28 2007-10-10 Lilly Co Eli COMPUESTOS DE PIRAZOLIL UREA CON ACTIVIDAD INHIBITORIA DE CINASA P38 Y FORMULACIoN FARMACÉUTICA QUE LO COMPRENDE
PE20070640A1 (es) * 2005-10-28 2007-08-10 Lilly Co Eli Compuestos derivados de pirazol-isoquinolina urea como inhibidores de la cinasa p38
TW200808723A (en) * 2006-03-13 2008-02-16 Univ California Conformationally restricted urea inhibitors of soluble epoxide hydrolase
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
WO2009002916A2 (en) * 2007-06-26 2008-12-31 Smithkline Beecham Corporation Processes for preparing benzimidazole thiophenes
US8314091B2 (en) 2007-08-20 2012-11-20 Msd Oss B.V. N-benzyl,N'-arylcarbonylpiperazine derivatives
KR20100124771A (ko) 2008-03-26 2010-11-29 다이이찌 산쿄 가부시키가이샤 신규 테트라하이드로이소퀴놀린 유도체
TW201022230A (en) * 2008-08-28 2010-06-16 Organon Nv 1-(4-ureidobenzoyl)piperazine derivatives
GB0818033D0 (en) 2008-10-02 2008-11-05 Respivert Ltd Novel compound
US8293748B2 (en) 2008-10-02 2012-10-23 Respivert Ltd. p38 MAP kinase inhibitors
CA2746357A1 (en) 2008-12-11 2010-06-17 Respivert Limited P38 map kinase inhibitors
MA33128B1 (fr) 2009-02-17 2012-03-01 Chiesi Farma Spa Derives de triazolopyridine utilises comme inhibiteurs de la p38 map kinase
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
US20110081316A1 (en) * 2009-10-02 2011-04-07 Vertex Pharmaceuticals Incorporated Pyrazole inhibitors of phosphatidylinositol 3-kinase
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US9296693B2 (en) 2010-01-29 2016-03-29 The Regents Of The University Of California Acyl piperidine inhibitors of soluble epoxide hydrolase
GB201009731D0 (en) 2010-06-10 2010-07-21 Pulmagen Therapeutics Inflamma Kinase inhibitors
MY170656A (en) 2011-12-09 2019-08-24 Chiesi Farm Spa Kinase inhibitors
SG11201402986RA (en) 2011-12-09 2014-12-30 Chiesi Farma Spa Kinase inhibitors
US9150570B2 (en) * 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
WO2014195402A1 (en) 2013-06-06 2014-12-11 Chiesi Farmaceutici S.P.A. Kinase inhibitors
AR107165A1 (es) 2015-12-23 2018-03-28 Chiesi Farm Spa Inhibidores de quinasa
WO2017108736A1 (en) 2015-12-23 2017-06-29 Chiesi Farmaceutici S.P.A. N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors
RU2731095C2 (ru) 2016-03-17 2020-08-28 Ф. Хоффманн-Ля Рош Аг Производное 5-этил-4-метил-пиразол-3-карбоксамида, обладающее активностью агониста taar
CN107619388A (zh) * 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
BR112020006677A2 (pt) 2017-10-05 2020-10-06 Fulcrum Therapeutics, Inc. uso de inibidores p38 para reduzir a expressão de dux4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
NZ514711A (en) * 1999-03-12 2004-02-27 Boehringer Ingelheim Pharma Compounds useful as anti-inflammatory agents
WO2003072569A1 (en) 2002-02-25 2003-09-04 Boehringer Ingelheim Pharmaceuticals, Inc. 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
GB0320244D0 (en) * 2003-05-06 2003-10-01 Aventis Pharma Inc Pyrazoles as inhibitors of tumour necrosis factor
JPWO2004101529A1 (ja) * 2003-05-19 2006-07-13 小野薬品工業株式会社 含窒素複素環化合物およびその医薬用途

Also Published As

Publication number Publication date
EP1761520B1 (en) 2008-07-09
US7767674B2 (en) 2010-08-03
WO2006009741A1 (en) 2006-01-26
EP1761520A1 (en) 2007-03-14
US20080306068A1 (en) 2008-12-11
DK1761520T3 (da) 2008-10-27
PL1761520T3 (pl) 2008-12-31
ES2308523T3 (es) 2008-12-01
SI1761520T1 (sl) 2008-10-31
ATE400567T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
SI1761520T1 (sl) Inhibitorji kinaze
MY143516A (en) Kinase inhibitors
TW200640924A (en) VEGF-R2 inhibitors and methods
IL163781A0 (en) Purine derivatives as kinase inhibitors
IL163777A0 (en) Kinase inhibitors
HK1154002A1 (en) Imidazopyridazinecarbonitriles useful as kinase inhibitors
MX2009007077A (es) Analogos de ciclopamina.
TW200624426A (en) BACE inhibitors
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
ZA200701137B (en) Triazolophthalazines
TNSN08191A1 (en) Kinase inhibitors
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
TN2011000293A1 (en) Protein kinase inhibitors
SG154433A1 (en) Phthalazine derivatives as parp inhibitors
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
JO2822B1 (en) Inhibitors of the enzyme kinase P70 S6 and AKT
MX2008001538A (es) Aril piridinas y metodos para su uso.
MX2010010406A (es) Tetrahidrofenantridinonas y tetrahidrociclopentaquinolinonas como inhibidores de la polimerizacion de poli(adp-ribosa)polimerasa-1 y tubulina.
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
ATE548364T1 (de) Aminopyrazolkinasehemmer
EP1891082A4 (en) NEW INHIBITORS OF PYRUVATE KINASE AS THERAPEUTIC AGENTS AGAINST CANCER
DOP2005000117A (es) Inhibidores de quinasa